{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:43:37Z","timestamp":1790826217375,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The identification of causative antigens for membranous nephropathy (MN) has revolutionized the comprehension of the pathophysiology of this autoimmune disease and its management. Recently, some studies described protocadherin FAT1 (FAT1) as a causal antigen in the context of hematopoietic stem cell transplantation (HSCT). The aim of this study was to investigate the large Viennese kidney biopsy collection at the Department of Pathology of the Medical University of Vienna and explore MN cases after HSCT for the causative antigen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifteen patients were identified with MN in diagnostic renal biopsies for proteinuria\/nephrotic syndrome after HSCT between 2001 and 2024. Cases were reviewed and tested for the expression of FAT1 by immunofluorescence specifically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Immunofluorescence showed that 12 out of 15 patients with MN had FAT1 expression, appearing 2.3 years after HSCT. In three patients without FAT1 expression, MN appeared 3.8 years after HSCT, with one testing positive for phospholipase A2 receptor (PLA2R) and two with unknown antigens. Serum creatinine for FAT1+\u00a0MN was 1.2\u00a0mg\/dl, while FAT1\u2212\u00a0MN was 1.3\u00a0mg\/dl. Proteinuria was 8\u00a0g\/g compared to 10.4\u00a0g\/g, respectively. IgG4 positivity was seen in 30% of FAT1+\u00a0MN cases. Over a follow up of 5.2 years, of the seven FAT1+\u00a0MN patients treated with rituximab, four achieved complete remission, two partial remission, and one was non-responsive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This hitherto largest single-center-cohort solidifies FAT1 as a causative antigen for MN in the setting of HSCT. However, not all post-HSCT-MN are related to FAT1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag005","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:35:36Z","timestamp":1768048536000},"source":"Crossref","is-referenced-by-count":1,"title":["Protocadherin FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation\u2014a cohort study with clinico-pathological correlations"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-0483","authenticated-orcid":false,"given":"Maja C","family":"Nackenhorst","sequence":"first","affiliation":[{"name":"Department of Pathology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Milovanovic","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mongera","sequence":"additional","affiliation":[{"name":"Nephrology Department, Bolzano Hospital ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"K\u00f6ller","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Passler","sequence":"additional","affiliation":[{"name":"Nephrology Department, Bolzano Hospital ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cejka","sequence":"additional","affiliation":[{"name":"Department of Nephrology , Hypertension, Transplant Medicine, Rheumatology, Geriatrics, Ordensklinikum Linz Elisabethinen, Linz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-620X","authenticated-orcid":false,"given":"Nicolas","family":"Kozakowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"2026032817373354900_bib1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026032817373354900_bib2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"2026032817373354900_bib3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/Exostosin 2-associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2026032817373354900_bib4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"2026032817373354900_bib5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"2026032817373354900_bib6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026032817373354900_bib7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","article-title":"Protocadherin 7-associated membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026032817373354900_bib8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfac237","article-title":"The many faces of NELL1 MN","volume":"16","author":"Sethi","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026032817373354900_bib9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2026032817373354900_bib10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2024.08.009","article-title":"FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection","volume":"106","author":"Sethi","year":"2024","journal-title":"Kidney Int"},{"key":"2026032817373354900_bib11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40620-023-01786-7","article-title":"A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation","volume":"37","author":"Mongera","year":"2024","journal-title":"J Nephrol"},{"key":"2026032817373354900_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ekir.2024.10.012","article-title":"De novo membranous nephropathy in renal allografts is associated with protocadherin FAT1","volume":"10","author":"Al-Rabadi","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026032817373354900_bib13","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.ekir.2025.07.046","article-title":"Temporal proteomic assessment of glomerular protocadherin FAT1 in de novo membranous nephropathy of the kidney allograft","volume":"10","author":"Batal","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026032817373354900_bib14","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.ekir.2021.04.033","article-title":"NELL1-Associated membranous glomerulopathy after hematopoietic stem cell transplantation","volume":"6","author":"Kudose","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026032817373354900_bib15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1523-1755.2005.00432.x","article-title":"Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney","volume":"68","author":"Yaoita","year":"2005","journal-title":"Kidney Int"},{"key":"2026032817373354900_bib16","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.1038\/ncomms10822","article-title":"FAT1 mutations cause a glomerulotubular nephropathy","volume":"7","author":"Gee","year":"2016","journal-title":"Nat Commun"},{"key":"2026032817373354900_bib17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.ekir.2021.01.023","article-title":"Expanding the spectrum of FAT1 nephropathies by novel mutations that affect hippo signaling","volume":"6","author":"Fabretti","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026032817373354900_bib18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.exphem.2005.12.011","article-title":"The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery","volume":"34","author":"Patriarca","year":"2006","journal-title":"Exp Hematol"},{"key":"2026032817373354900_bib19","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"2026032817373354900_bib20","first-page":"42","article-title":"Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation","volume":"6","author":"Teshima","year":"2023","journal-title":"Blood Cell Ther"},{"key":"2026032817373354900_bib21","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3389\/fimmu.2018.03035","article-title":"Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy","volume":"9","author":"von Haxthausen","year":"2018","journal-title":"Front Immunol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag005\/66339739\/sfag005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag005\/66339739\/sfag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag005\/66339739\/sfag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:37:39Z","timestamp":1774733859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag005\/8419680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag005","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,1,10]]},"article-number":"sfag005"}}